Advertisement

Topics

Mount Sinai researchers win a contract from DARPA to develop technology that measures threat exposures

16:38 EDT 13 Jun 2019 | News-Medical.net

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a contract from the Defense Advanced Research Projects Agency, a research agency within the U.S. Department of Defense, to find molecular signatures in blood that identify previous exposures and time of exposure to materials that could be associated with weapons of mass destruction (including infectious agents, chemicals, and radiation).

Original Article: Mount Sinai researchers win a contract from DARPA to develop technology that measures threat exposures

NEXT ARTICLE

More From BioPortfolio on "Mount Sinai researchers win a contract from DARPA to develop technology that measures threat exposures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...